Once a Week IV Dalbavancin for Skin Infections

Once a Week IV Dalbavancin for Skin Infections

Worth the Cost?

Once-weekly Dalbavancin might reduce admissions, but it introduces new concerns about antibiotic resistance and high costs

Washington’s Ban on Psych Boarding

Washington’s Ban on Psych Boarding

On the Brink

A cry for help or savvy brinkmanship?

Craig Spencer's Data Collection Project Fuels Innovation

Craig Spencer's Data Collection Project Fuels Innovation

EPI Journal

Rwandan fellowship project gives insight into the value for reliable data and the need for experienced local partners

In Memoriam: Gail Anderson

In Memoriam: Gail Anderson

1925 – 2014

Founding Father of Emergency Medicine

Market Forces

Market Forces

The Recruiter

Today’s EM job market: Know your target regions, tailor your goals and set yourself up for success

Doctors Say the Craziest Things

Doctors Say the Craziest Things

Financial Consult

Emergency physicians say some strange things when they're explaining their investment strategies. Here are four phrases to avoid

Go Big (Data) or Go Home

Go Big (Data) or Go Home

ED Benchmarking

Variations in practice make granular benchmarking comparisons troublesome. Fortunately, the EDBA’s big data has your back

Consider Tranexamic Acid for Traumatic Hemorrhage

Consider Tranexamic Acid for Traumatic Hemorrhage

Journal Club

Why the early use of TXA should be strongly considered for any patient requiring blood products for trauma-related hemorrhage

Greg Henry's ACEP Odyssey

Greg Henry's ACEP Odyssey

Welcome to the City of the Big Shoulders

The Unauthorized Guide to the ACEP Scientifc Assembly

Keeping an Eye on 72-Hour Bouncebacks

Keeping an Eye on 72-Hour Bouncebacks

Director's Corner

Dear Director, My CEO is concerned about our ED’s quality because we’ve experienced a recent increase in our 72-hour returns…

Flips, Falls and Other Orthopedic Adventures

Flips, Falls and Other Orthopedic Adventures

Practical Pediatrics

How to narrow down the diagnosis of pediatric leg pain when all categories of hip pain remain on the differential

Open Injuries to Flexor Compartment of Fingers and Hands

Open Injuries to Flexor Compartment of Fingers and Hands

Core Knowledge

Visualize, visualize, visualize. The decision to resort to surgery is multifaceted, based on location of injury, amount of damage and…

'Hey Doc, I Just Can't Pee'

'Hey Doc, I Just Can't Pee'

Ultrasound

You’ve got a seemingly straightforward complaint. Should you reach for your Foley or your ultrasound probe?

So EHRs Don’t Hurt Patient Sat or Throughput. Next?

So EHRs Don’t Hurt Patient Sat or Throughput. Next?

Measuring EHR Effectiveness

EHR usability needs to improve, but we need to focus on patient safety issues 

EHRs Are Inevitable, Yet Studies Still Pose Serious Questions

EHRs Are Inevitable, Yet Studies Still Pose Serious Questions

Measuring EHR Effectiveness

We’re seeing a dramatic increase in testing and a shocking amount of physician time being spent on electronic medical records

DEA Shifts Hydrocodone to Schedule II

DEA Shifts Hydrocodone to Schedule II

Fed’s Clamp Down on Hydrocodone

A good pill is hard to find - The reclassification of hydrocodone may make some EPs reluctant to prescribe it

When Ebola Shows Up At Your ED

When Ebola Shows Up At Your ED

Facts and Risk Levels

"Hey Dr T! We’ve got an Ebola suspect in room 64 for you. Don’t worry, we’ll walk you through this."

Frontpage Slideshow | Copyright © 2006-2014 JoomlaWorks Ltd.
Print
E-mail
Reprint

You hear some cries coming from down the hall and as you enter the patient’s room you find a frustrated mother with 2 children (2 and 4 years old) who she reports have been pulling at their ears, acting fussy and have had fever. As you try to wrestle them and that unruly otoscope to get a glimpse at the TMs , you wonder if all those other prescriptions you have written today were worth it, or if these children with otitis media would experience relief from their ear ache without your intervention.

Acute otitis media (AOM) is the number one diagnosis associated with antibiotic prescriptions in children. Previous meta-analyses have suggested a Number Needed to Treat of 17 children to eliminate otalgia in one child at 2 to 7 days post-diagnosis. In 2006, a meta-analysis of six randomized controlled trials suggested that children under age 2-years with bilateral otitis or any age with otorrhea are most likely to benefit from antibiotics as manifest by a reduction in 3-7 day pain scores. The meta-analysis also identified no cases of mastoiditis or other serious complications suggesting the incidence of AOM adverse outcomes is extremely low. With the increasing concern for promotion of antibiotic resistance with unnecessary prescriptions, physicians have started to question the routine prescribing of antibiotics for AOM.

Previous studies of a wait-and-see approach have been done in a pediatrician’s office. This randomized, controlled trial was unique in that it took place in the ED in an environment where patients did not have a pre-existing relationship with the treating physician. This randomized controlled trial was completed over a one year period on children age 6 months to 12 years of age presenting to an emergency department and diagnosed with AOM. The children were randomized to receive either a standard prescription for an antibiotic or a wait-and-see prescription. All children also received ibuprofen and otic analgesic drops for pain control. Follow-up was conducted 3 times to determine outcomes such as rate at which prescriptions were filled, clinical course of the illness, unscheduled returns for medical care, and comfort with the wait-and-see method for future occurrences of otitis media. A wait-and-see prescription was a prescription that included instructions both verbal and written that states the caregiver was only to fill and administer the medication if the child was either not better or is worse in 48 hours from the visit. Parents in the standard group were encouraged to immediately fill the prescription and start treatment. Patients were excluded from the trial is they had intercurrent bacterial infection such as pneumonia, patient appeared “toxic” or was admitted. Other exclusion criteria included immunocompromise, myringotomy tubes or perforated TM, antibiotic use within 7 days, or when unable to be interviewed in follow-up due to language or lack of telephone. AOM was diagnosed and treated at the discretion of the ED physician. Amoxicillin was prescribed in greater than 90% of the cases with high dose treatment being given to most patients less than 2 years of age.

This study showed a statistically significant finding that prescriptions were not filled for 62% of children in the wait-and-see group vs. 13% in the standard prescription group. Parents who filled the wait-and-see prescriptions reported they did so because of fever (60%), otalgia (24%) and fussiness (6%). No serious adverse events occurred in either group and there was no difference in unscheduled medical visits. Otalgia was more common in the wait-and-see group while diarrhea was more common in the standard prescription group.

Overall the wait-and-see prescription for AOM diagnosed in the ED significantly decreases the use of antibiotics. Although there was a slightly longer course of otalgia (0.4 days) in the wait-and-see group, this was balanced against the 2-3 fold higher incidence of diarrhea in the standard prescription group. Not to mention even though there was a statistically significant difference, does 1/2 a day result in a clinically significant difference. The wait-and-see approach may be helpful in decreasing the problem of antibiotic resistance without increasing the risk of complications or return visits for untreated AOM. Although an immediate prescription may decrease the duration of otalgia this must be weighed against the risk of antibiotic use in what, for the most part, is a self-limited disease.

To get the full article please go to http://pmid.us/16968847

 

 


 
 

Add comment

Security code
Refresh

Popular Authors

  • Greg Henry
  • Rick Bukata
  • Mark Plaster
  • Kevin Klauer
  • Jesse Pines
  • David Newman
  • Rich Levitan
  • Ghazala Sharieff
  • Nicholas Genes
  • Jeannette Wolfe
  • William Sullivan
  • Michael Silverman

Subscribe to EPM